- Expires: December 28, 2022
- Credit: 1.00hr(s)
- CME
- Therapeutic Areas: Oncology, Urologic oncology
- Specialties: urothelial carcinoma (UC)
- On-Demand
Modern Management of ITP: Thinking Beyond the Conventional Therapies
- Available: March 8, 2022 —
- March 7, 2023
- Credit: 0.50hr(s)
- Credit Types: CME
- Therapeutic Areas: Hematology, Oncology
- Location: Internet Enduring Activity
Course Description
In this animated, visually-enhanced activity, an expert in hematology-oncology discusses current standards for diagnosing and treating idiopathic thrombocytopenic purpura—and provides an update on the challenges associated with modern care and the promise of novel therapeutic options for disease management.
Other Courses in this Series
Other Courses That May be of Interest
- Series: CLL/SLL
- Expires: December 14, 2023
- Credit: 0.30hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Chronic Lymphocytic Leukemia (CLL), Small lymphocytic lymphoma (SLL)
- Series: NSCLC
- Expires: November 28, 2023
- Credit: 0.30hr(s)
- NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC
- Series: CLL/SLL
- Expires: December 14, 2023
- Credit: 0.30hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Chronic Lymphocytic Leukemia (CLL), Small lymphocytic lymphoma (SLL)
- Series: NSCLC
- Expires: November 28, 2023
- Credit: 0.15hr(s)
- NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC
- Series: CLL/SLL
- Expires: December 14, 2023
- Credit: 0.30hr(s)
- AAPA, CME, CPE, NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Chronic Lymphocytic Leukemia (CLL), Small lymphocytic lymphoma (SLL)
- Series: NSCLC
- Expires: November 28, 2023
- Credit: 0.15hr(s)
- NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC
- Series: NSCLC
- Expires: November 28, 2023
- Credit: 0.30hr(s)
- NCPD
- Therapeutic Areas: Hematologic Oncology, Oncology
- Specialties: Biomarkers, NSCLC